Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus Editorial


Authors: Henson, C. E.; Morton, D. J.; Mayadev, J. S.; Wong, S. J.; Zamarin, D.
Title: Cancer trials as opportunities to serve and learn from individuals with human immunodeficiency virus
Keywords: cancer survival; treatment outcome; nonhuman; patient selection; solid tumor; note; united states; human immunodeficiency virus infection; antineoplastic agent; neoplasm; neoplasms; colorectal cancer; disease association; cancer immunotherapy; immune system; multiple myeloma; breast cancer; lung cancer; practice guideline; food and drug administration; cancer research; cancer therapy; cancer mortality; high risk patient; prostate cancer; health care quality; patient participation; head and neck cancer; uterine cervix cancer; comorbidity; medical society; clinical research; oropharynx cancer; human immunodeficiency virus; antiretrovirus agent; cd4 lymphocyte count; highly active antiretroviral therapy; virus load; anus cancer; proteinase inhibitor; clinical trials; health care access; hiv infections; hiv; cervical cancer; wart virus; virus dna; clinical trial (topic); vulva cancer; human immunodeficiency virus infected patient; papillomavirus infection; anal cancer; oncologist; nelfinavir; antiretroviral therapy; clinical trial registry; humans; human; human immunodeficiency virus (hiv); malignant neoplasm; tumor virus; person living with human immunodeficiency virus (plwh)
Journal Title: Cancer
Volume: 129
Issue: 5
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2023-03-01
Start Page: 664
End Page: 667
Language: English
DOI: 10.1002/cncr.34598
PUBMED: 36576320
PROVIDER: scopus
DOI/URL:
Notes: Note -- Export Date: 1 March 2023 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dmitriy Zamarin
    201 Zamarin